Samsara BioCapital, L.P. - Insider Trading & Ownership

Entity
Company
Location
628 Middlefield Road, Palo Alto, CA
Summary
The estimated value of insider holdings of Samsara BioCapital, L.P. is at least $34.7M dollars as of April 13, 2022. Samsara BioCapital, L.P. is the 10%+ Owner of Graphite Bio, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $34.7M.
All Insider Reports
All Insider Reports

Ownership of Samsara BioCapital, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LENZ LENZ Therapeutics, Inc. 10%+ Owner $34.7M Apr 11, 2022

Insider Transactions Reported by Samsara BioCapital, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.